Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
10/10/2012 | CN102716083A Lafutidine liposome solid preparation and preparing method thereof |
10/10/2012 | CN102715509A Health care product with function of expelling noxious substances to keep young |
10/10/2012 | CN102304456B Health care medicinal wine |
10/10/2012 | CN102258474B Preparation method of self-microemulsifying coenzyme Q10 powdery dry emulsion |
10/10/2012 | CN102250732B Tussah female moth beautifying wine for women, and production process thereof |
10/10/2012 | CN102228687B Freeze-dried live attenuated hepatitis A vaccine not containing gelatin or human albumin protective agent and preparation method for freeze-dried live attenuated hepatitis A vaccine |
10/10/2012 | CN102225063B Pantoprazole sodium composition for injection |
10/10/2012 | CN102218078B Rifaximin suspension containing montmorillonite and preparation method thereof |
10/10/2012 | CN102178791B Toxin expelling and acne removing agent and preparation method and use method thereof |
10/10/2012 | CN102178745B Decumbent corydalis tuber vacuum freeze drying process and preparation process for decumbent corydalis tuber powder |
10/10/2012 | CN102161963B Grass root wine and preparation method thereof |
10/10/2012 | CN102139058B Traditional Chinese medicine for treating stomach diseases |
10/10/2012 | CN102091116B Medicine membrane for treating dental ulcer and preparation method thereof |
10/10/2012 | CN102049032B Oral liquid capable of strengthening spleen, replenishing qi and nourishing blood and preparation method thereof |
10/10/2012 | CN102038661B Oleanolic acid osmotic pump tablet and preparation method thereof |
10/10/2012 | CN101966282B Traditional Chinese medicine for treating stomach diseases |
10/10/2012 | CN101933653B Officinal health-care solid electronic aerosolization liquid and preparation method thereof |
10/10/2012 | CN101912383B Application of E-ring demethoxy-silibinin for preparing medicament for treating viral hepatitis B |
10/10/2012 | CN101890086B Medicament for treating stomach disease |
10/10/2012 | CN101843337B Method for preparing probiotics tablets |
10/10/2012 | CN101816639B Tablets of mosapride citrate and preparation method thereof |
10/10/2012 | CN101775347B Health-care vinegar, vinegar drink preparation method and anti-alcohol liver-protection application thereof |
10/10/2012 | CN101745095B Composition of reduced glutathione and sodium carbonate or sodium bicarbonate |
10/10/2012 | CN101647771B Silybin dihemisuccinate disodium oral preparation and preparation method thereof |
10/10/2012 | CN101637492B Preparation method of total flavonoids in persimmon leaves |
10/10/2012 | CN101485685B Application of mesenchymal stem cells in preparing medicament for treating autoimmune disease |
10/10/2012 | CN101472921B Pyridylisoxazole derivative |
10/10/2012 | CN101450934B Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
10/10/2012 | CN101411779B Chinese medicine effective component composition for treating liver cancer and method for preparing the same |
10/10/2012 | CN101400670B Novel pyridine derivative having anti-helicobacter pylori activity |
10/10/2012 | CN101244064B Pharmaceutical combination for preventing and treating motion sickness and preparations thereof |
10/10/2012 | CN101129368B Freeze-dried powder needle containing lansoprazole |
10/10/2012 | CN101128487B Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY |
10/10/2012 | CN101095837B Decoction medicine for treating dry and hard excrement type chronic bronchitis and method for preparing the same |
10/09/2012 | US8283164 Liver engrafting cells, assays, and uses thereof |
10/09/2012 | US8283135 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
10/09/2012 | US8282933 genetic engineered proteins useful as immunogens in vaccines; prevention of periodontal disease |
10/09/2012 | CA2633516C Elongase genes and uses thereof |
10/09/2012 | CA2556944C Thiazole derivative |
10/09/2012 | CA2338712C Use of creatine compounds for treatment of bone or cartilage cells and tissues |
10/04/2012 | WO2012135589A1 Methods of administering beta7 integrin antagonists |
10/04/2012 | WO2012135426A2 Anti-bacterial and mineralizing calcium phosphate compositions |
10/04/2012 | WO2012134828A1 Methods for treating heartburn and/or preventing gastric bleeding or hemorrhage in patients receiving clopidogrel therapy |
10/04/2012 | WO2012133814A1 Therapeutic agent for cancer, and method for determining prognosis of cancer |
10/04/2012 | WO2012133792A1 Protein-containing composition and method for producing same |
10/04/2012 | WO2012133198A1 Nutritional composition for inflammatory diseases |
10/04/2012 | WO2012131728A2 A herbal medication to cure bloat in animals |
10/04/2012 | WO2012131715A2 A herbal medication to cure jaundice |
10/04/2012 | WO2012131643A1 Herbal compositions comprising pedilanthus tithymaloides for treatment prevention of gastrointestinal disorder |
10/04/2012 | WO2012131069A1 Short chain fatty acids and their derivatives for use in treatment immunogenic disorders |
10/04/2012 | WO2012131061A1 Treatment for infection with hepatitis b virus alone or in combination with hepatitis delta virus and associated liver diseases |
10/04/2012 | WO2012130679A1 New azaspirodecanone compounds as hsl inhibitors |
10/04/2012 | WO2012130351A1 Composition for use for digestive problems |
10/04/2012 | WO2012129847A1 Methods for simultaneously determinating multi-component of simotang and fingerprint building method thereof |
10/04/2012 | WO2012091440A3 Composition for improvement, treatment and prevention of gastrointestinal motility disorders |
10/04/2012 | WO2012081947A3 Vaccine for inducing an improved immune reaction |
10/04/2012 | WO2012070890A3 Pharmaceutical composition comprising extract of lonicera japonica for prevention and treatment of gastroesophageal reflux disease |
10/04/2012 | US20120253041 New phenylalanine derivatives |
10/04/2012 | US20120252869 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt) |
10/04/2012 | US20120252865 Carbamate derivatives in particular for the treatment of neurological disorders |
10/04/2012 | US20120252864 Substituted isoindoline-1,3-dione derivatives |
10/04/2012 | US20120252848 Liquid dosage forms of non-enterically coated acid-labile drugs |
10/04/2012 | US20120252847 Novel form of s-omeprazole |
10/04/2012 | US20120252837 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
10/04/2012 | US20120252830 Substituted Aminobutyric Derivatives as Neprilysin Inhibitors |
10/04/2012 | US20120252824 Drug Combinations and Uses in Treating a Coughing Condition |
10/04/2012 | US20120252817 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES |
10/04/2012 | US20120252810 Fatty acid non-flushing niacin derivatives and their uses |
10/04/2012 | US20120252798 Indole compounds as an inhibitor of cellular necrosis |
10/04/2012 | US20120252790 Amino-Derivatives As Novel Inhibitors Of Histone Deacetylase |
10/04/2012 | US20120252789 Inhibitors of sphingosine kinase |
10/04/2012 | US20120252788 5ht2c receptor modulators |
10/04/2012 | US20120252778 Pyrazolo pyrimidine derivatives |
10/04/2012 | US20120252777 Thiazolopyrimidine compounds |
10/04/2012 | US20120252760 Novel pyridopyrazines and their use as modulators of kinases |
10/04/2012 | US20120252747 Macrocyclic compounds and methods of making and using the same |
10/04/2012 | US20120252740 Hdac inhibitors and therapeutic methods of using same |
10/04/2012 | US20120252732 Albumin fusion proteins |
10/04/2012 | US20120252728 Val (8) GLP-1 Composition and Method for Treating Functional Dyspepsia and/or Irritable Bowel Syndrome |
10/04/2012 | US20120252725 Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders |
10/04/2012 | US20120252723 Regulating the Amino Acid Pool Used for the Acute-Phase Protein Synthesis |
10/04/2012 | US20120252722 Metal-binding therapeutic peptides |
10/04/2012 | US20120252721 Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor |
10/04/2012 | US20120252097 Therapeutic Agents Comprising Pro-Apoptotic Proteins |
10/04/2012 | US20120251631 Methods of treating or preventing peritonitis with oxidative reductive potential water solution |
10/04/2012 | US20120251593 Silk fibroin-decorin scaffolds |
10/04/2012 | US20120251567 Liver function enhancing composition |
10/04/2012 | US20120251550 Crystalline anti-hTNFalpha antibodies |
10/04/2012 | US20120251549 Complement inhibitors and uses thereof |
10/04/2012 | US20120251547 Il-17 receptor a antigen binding proteins |
10/04/2012 | US20120251539 Methods and Compositions for the Treatment of Immune Disorders |
10/04/2012 | US20120251533 Monoclonal antibodies against cd30 lacking in fucosyl residues |
10/04/2012 | US20120251532 Anti-alpha v beta 6 antibodies |
10/04/2012 | US20120251519 Endopeptidase Treatment of Smooth Muscle Disorders |
10/04/2012 | US20120251504 Pluripotent stem cells obtained from dental pulp |
10/04/2012 | US20120251498 Gene Delivery to Organs |
10/04/2012 | US20120251495 Pterin based therapies for inflammatory conditions |
10/04/2012 | US20120251493 Novel macrocyclic inhibitors of hepatitis c virus replication |
10/04/2012 | US20120251492 Triterpene derivative and agent for preventing or treating chronic hepatitis c |
10/04/2012 | US20120251486 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same |